Search Results - "Dawood, Reham M"

Refine Results
  1. 1

    The Impact of COVID-19 on Liver Injury by Dawood, Dr. Reham M., Salum, Ghada Maher, El-Meguid, Mai Abd

    “…The current coronavirus disease outbreak of 2019 (COVID-19) has led to a global pandemic. The principal cause of mortality in COVID-19 is represented lung…”
    Get full text
    Journal Article
  2. 2

    A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice by Dawood, Reham M, Moustafa, Rehab I, Abdelhafez, Tawfeek H, El-Shenawy, Reem, El-Abd, Yasmine, Bader El Din, Noha G, Dubuisson, Jean, El Awady, Mostafa K

    Published in BMC infectious diseases (05-11-2019)
    “…Although DAAs hold promise to significantly reduce rates of chronic HCV infections, its eradication still requires development of an effective vaccine…”
    Get full text
    Journal Article
  3. 3

    Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2 by Dawood, Reham M., El-Meguid, Mai A., Salum, Ghada M., El-Wakeel, Khaled, Shemis, Mohamed, El Awady, Mostafa K.

    Published in Journal of infection and public health (01-02-2021)
    “…The striking difference in severity of SARS CoV2 infection among global population is partly attributed to viral factors. With the spike (S) and nucleocapsid…”
    Get full text
    Journal Article
  4. 4

    Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients by Salum, Ghada M., Dawood, Reham M., Abd el-Meguid, Mai, Ibrahim, Noha E., Abdel Aziz, Ashraf O., El Awady, Mostafa K.

    Published in Genes & diseases (01-09-2020)
    “…In Egypt, Sofosbuvir (SOF) in combination with Dataclasvir (DCV) is the broadly used DAAs with excellent therapeutic profile. This study is designed to explore…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis by Ibrahim, Marwa K, Salum, Ghada Maher, Bader El Din, Noha G, Dawood, Reham M, Barakat, Ahmed, Khairy, Ahmed, El Awady, Mostafa K

    Published in PloS one (02-05-2016)
    “…IFN orchestrates the expression of various genes to halt hepatitis C virus (HCV) replication with the possibility of either reduced or increased liver…”
    Get full text
    Journal Article
  7. 7

    Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients by Dawood, Reham M., El-Meguid, Mai Abd, Shousha, Hend Ibrahim, Elsayed, Ahmed, Nabeel, Mohamed Mahmoud, Yosry, Ayman, Abdelaziz, Ashraf, Salum, Ghada M.

    Published in Heliyon (01-08-2022)
    “…HCV damages the hepatocytes ending with hepatocellular carcinoma (HCC). The direct-acting antivirals (DAAs) treatment has raised hopes for reducing the…”
    Get full text
    Journal Article
  8. 8

    Vascular Endothelial Growth Factor Expression in Hepatitis C Virus-Induced Liver Fibrosis: A Potential Biomarker by Salum, Ghada M, Bader El Din, Noha G, Ibrahim, Marwa K, Anany, Mohamed A, Dawood, Reham M, Khairy, Ahmed, El Awady, Mostafa K

    Published in Journal of interferon & cytokine research (01-07-2017)
    “…The major complication of hepatitis C virus (HCV) infection is the induction of hepatic fibrosis. In this study, we investigated the correlation between the…”
    Get more information
    Journal Article
  9. 9

    Tumor necrosis factor-α-G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients by Bader El Din, Noha G, Farouk, Sally, El-Shenawy, Reem, Ibrahim, Marwa K, Dawood, Reham M, Elhady, Mostafa M, Salem, Ahmed M, Zayed, Naglaa, Khairy, Ahmed, El Awady, Mostafa K

    Published in World journal of gastroenterology : WJG (14-09-2016)
    “…AIM To investigate the association of tumor necrosis factor alpha(TNFα)-G308 A polymorphism with different liver pathological changes in treatment-na?ve…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Biochemical differences between nano- and normal formulation of tamoxifen and other natural bioactive materials ameliorate breast cancer in experimental rats by Ezzat, Afaf, Abdelhamid, Abdou Osman, El Awady, Mostafa K., Dawood, Reham M., Mohammed, Dina Mostafa

    Published in Bulletin of the National Research Centre (21-04-2021)
    “…Background Human breast cancer is the most prevalent malignancy in women all-over the world. The aim is to look further into the effectiveness of the…”
    Get full text
    Journal Article
  12. 12

    Expression of Reactive Oxygen Species-Related Transcripts in Egyptian Children With Autism by Meguid, Nagwa A, Ghozlan, Said A S, Mohamed, Magda F, Ibrahim, Marwa K, Dawood, Reham M, Bader El Din, Noha G, Abdelhafez, Tawfeek H, Hemimi, Maha, El Awady, Mostafa K

    Published in Biomarker Insights (2017)
    “…The molecular basis of the pathophysiological role of oxidative stress in autism is understudied. Herein, we used polymerase chain reaction (PCR) array to…”
    Get full text
    Journal Article
  13. 13

    HCV Therapy Follow-up Fractionation (CTF2) by Intra-PBMC Nested RNA PCR Recognizes Early Virologic Response and Relapse by Abd Alla, Mohamed Darwish Ahmed, Elibiary, Saleh Ahmed, Elshaboury, Ramy Hassan, Wu, George Y, Dawood, Reham M, El Awady, Mostafa Kamel

    “…Sustained virologic response is evaluated by single-step reverse transcription (SRT) PCR assay, which assesses hepatitis C virus (HCV) clearance from plasma…”
    Get full text
    Journal Article
  14. 14

    Comprehensive assessment of circulatory miRNAs as potential diagnostic markers in HCV recurrence post liver transplantation by Salum, Ghada M., Abd El Meguid, Mai, Fotouh, Basma E., Abdel Aziz, Ashraf O., Dawood, Reham M.

    “…HCV recurrence after liver transplantation is one of the causal agents for graft rejection. This study aims to profile non-invasive biomarkers in patients with…”
    Get full text
    Journal Article
  15. 15

    Predictors of Disease Recurrence Post Living Donor Liver Transplantation in End Stage Chronic HCV Patients by Dawood, Reham M., Abdel Aziz, Ashraf O., El Awady, Mostafa K., Hunter, Shereen Shoukry, Elbaz, Tamer Mahmoud, Abdelhafez, Tawfeek H., Bader El Din, Noha G., Abdel Aziz Riad, Mahmoud, Omran, Moataza H.

    Published in Disease markers (01-01-2014)
    “…HCV recurrence represents a universal phenomenon after liver transplantation. In this study Fifty HCV patients who underwent living donor liver transplantation…”
    Get full text
    Journal Article
  16. 16

    Recipient interleukin 6 gene polymorphism and expression predict HCV recurrence post liver transplantation by Dawood, Reham M., Salum, Ghada M., Abd El-Meguid, Mai, Shemis, Mohamed, Abdel Aziz, Ashraf O., El Awady, Mostafa K.

    Published in Gene (05-09-2020)
    “…•Host factors controlling post LTX recurrence probably mimic chronic HCV related cirrhosis.•High levels of IL-6 are linked with higher risk of Hepatocellular…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Bioactive glass doped with noble metal nanoparticles for bone regeneration: in vitro kinetics and proliferative impact on human bone cell line by Mostafa, Amany A, El-Sayed, Mayyada M H, Emam, Ahmed N, Abd-Rabou, Ahmed A, Dawood, Reham M, Oudadesse, Hassane

    Published in RSC advances (25-07-2021)
    “…This work investigates the bioactivity of novel silver-doped (BG-Ag) and gold-doped (BG-Au) quaternary 46S6 bioactive glasses synthesized a semi-solid-state…”
    Get full text
    Journal Article
  19. 19

    Polymorphism in Variable Number of Tandem Repeats of Dopamine D4 Gene Is a Genetic Risk Factor in Attention Deficit Hyperactive Egyptian Children: Pilot Study by Shahin, Ola, Meguid, Nagwa A., Raafat, Omnia, Dawood, Reham M., Doss, Malak, Din, Noha G. Bader El, Awady, Mostafa K. El

    Published in Biomarker Insights (01-01-2015)
    “…Introduction The variable number of tandem repeats (VNTR) of the dopamine receptor D4 (DRD4) gene among humans may elucidate individual differences in…”
    Get full text
    Journal Article
  20. 20

    Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians by Dawood, Reham M., Salum, Ghada M., El-Meguid, Mai Abd, Elsayed, Ahmed, Yosry, Ayman, Abdelaziz, Ashraf, Shousha, Hend Ibrahim, Nabeel, Mohamed Mahmoud, El Awady, Mostafa K.

    Published in Microbial pathogenesis (01-04-2021)
    “…Complex diseases such as fibrosis are likely polygenic. Lately, cirrhosis risk score (CRS) clearly discriminated Chronic HCV patients with high-risk versus…”
    Get full text
    Journal Article